This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
An overview of the major forces behind stock index movements, with guidance on tracking catalysts and assessing risk.
21,624 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
PayPal stock has been grabbing headlines with a rapid rise tied to buyout chatter and a strategic turnaround. This gu...
A senior Rogers Corp. executive sold 830 shares for about $113,000, sparking questions about what it means for the st...
When a blue-chip stock posts a stunning earnings beat, investors flock to understand what comes next. This guide brea...
Investors often wrestle with where to place bets: a volatile crypto project or a disruptive nuclear-tech equity. This...
A thoughtful, real-world guide to deciding whether to buy Amazon before July earnings. Learn how to weigh growth driv...
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
When a legendary investor shifts big positions, traders sit up. This piece breaks down what it could mean that billio...
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
A Sunrun director recently disposed of a large block of shares. This article breaks down insider sales, what they imp...
A major adviser boosted its stake in Savara by more than a million shares during the latest quarter, wading into a bi...
SkyWater Technology just posted a record revenue figure, but the CFO sold about $2.5 million worth of stock. This art...